Cargando…

Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients

The aim of the retrospective study was to compare the immunophenotyping of T-lymphocytes, B-lymphocytes, and natural killer cells before the administration of the first and the second dose of ocrelizumab in 22 patients with multiple sclerosis in a three-year period (2019–2021) at the Department of N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radmilo, Marija, Pavelin, Sanda, Vujović, Igor, Šoda, Joško, Rogić Vidaković, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953738/ https://www.ncbi.nlm.nih.gov/pubmed/36830890 http://dx.doi.org/10.3390/biomedicines11020353

Ejemplares similares

Assessment of Motor Evoked Potentials in Multiple Sclerosis
por: Šoda, Joško, et al.
Publicado: (2023)

Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients—The Example of Croatia
por: Jerković, Ana, et al.
Publicado: (2022)

Psychometric Properties of the Pittsburgh Sleep Quality Index (PSQI) in Patients with Multiple Sclerosis: Factor Structure, Reliability, Correlates, and Discrimination
por: Jerković, Ana, et al.
Publicado: (2022)

Expression of CD40 and CD192 in Classical Monocytes in Multiple Sclerosis Patients Assessed with Transcranial Magnetic Stimulation
por: Režić Mužinić, Nikolina, et al.
Publicado: (2023)

Transcranial Magnetic Stimulation Measures, Pyramidal Score on Expanded Disability Status Scale and Magnetic Resonance Imaging of Corticospinal Tract in Multiple Sclerosis
por: Rogić Vidaković, Maja, et al.
Publicado: (2023)

Exploring Neurophysiological Mechanisms and Treatment Efficacies in Laryngeal Dystonia: A Transcranial Magnetic Stimulation Approach
por: Rogić Vidaković, Maja, et al.
Publicado: (2023)

Obstructive Sleep Apnea Syndrome: A Preliminary Navigated Transcranial Magnetic Stimulation Study
por: Rogić Vidaković, Maja, et al.
Publicado: (2020)

Using Cutaneous Receptor Vibration to Uncover the Effect of Transcranial Magnetic Stimulation (TMS) on Motor Cortical Excitability
por: Vidaković, Maja Rogić, et al.
Publicado: (2020)

The Cortical Silent Period in the Cricothyroid Muscle as a Neurophysiologic Feature for Dystonia Observation: E-Field-Navigated Transcranial Magnetic (TMS) Study
por: Konstantinović, Ivan, et al.
Publicado: (2023)

The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor Cortex
por: Rogić Vidaković, Maja, et al.
Publicado: (2022)

Influence of 3D printing properties on relative dielectric constant in PLA and ABS materials
por: Kuzmanić, Ivica, et al.
Publicado: (2023)

Every Vessel Counts: Neural Network Based Maritime Traffic Counting System
por: Petković, Miro, et al.
Publicado: (2023)

Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients
por: Gingele, Stefan, et al.
Publicado: (2018)

Information Processing Speed Assessed with Letter Digit Substitution Test in Croatian Sample of Multiple Sclerosis Patients
por: Jerković, Ana, et al.
Publicado: (2022)

Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
por: Smets, I., et al.
Publicado: (2021)

B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
por: Reddy, Venkat, et al.
Publicado: (2013)

Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
por: Emery, Paul, et al.
Publicado: (2014)

Ocrelizumab-Induced Severe Colitis
por: Lee, Hsing Hwa, et al.
Publicado: (2020)

Editorial: The Neurophysiology of Developmental Stuttering: Unraveling the Mysteries of Fluency
por: Busan, Pierpaolo, et al.
Publicado: (2022)

Ocrelizumab: A Review in Multiple Sclerosis
por: Lamb, Yvette N.
Publicado: (2022)

An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis: Immunotherapy with rituximab, ocrelizumab, and ofatumumab
por: Ovchinnikov, Arkady, et al.
Publicado: (2022)

Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab
por: Landi, Doriana, et al.
Publicado: (2022)

P300 Wave Changes in Patients with Multiple Sclerosis
por: Ivica, Nikolina, et al.
Publicado: (2013)

Ocrelizumab zur Behandlung der Multiplen Sklerose
por: Graf, Jonas, et al.
Publicado: (2020)

Endocarditis following ocrelizumab in relapsing-remitting MS
por: Faissner, Simon, et al.
Publicado: (2020)

Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
por: Cellerino, Maria, et al.
Publicado: (2021)

Ocrelizumab: a new milestone in multiple sclerosis therapy
por: Mulero, Patricia, et al.
Publicado: (2018)

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
por: Turner, Benjamin, et al.
Publicado: (2019)

COVID-19 in ocrelizumab-treated people with multiple sclerosis
por: Hughes, Richard, et al.
Publicado: (2021)

Ocrelizumab/rituximab: Various toxicities: 6 case reports
Publicado: (2021)

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology
por: Mancinelli, Chiara Rosa, et al.
Publicado: (2021)

Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis
por: Chey, Shin Yee, et al.
Publicado: (2022)

Ocrelizumab: Coronavirus disease-2019 : 15 case reports
Publicado: (2022)

Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
por: Hallin, Erik I., et al.
Publicado: (2022)

Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients
por: Akgün, Katja, et al.
Publicado: (2022)

No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS)
por: Kister, Ilya, et al.
Publicado: (2023)

The Associations of Neutrophil–Lymphocyte, Platelet–Lymphocyte, Monocyte–Lymphocyte Ratios and Immune-Inflammation Index with Negative Symptoms in Patients with Schizophrenia
por: Šagud, Marina, et al.
Publicado: (2023)

A second retrospective database analysis confirms prior findings of apparent increased cardiovascular comorbidities in hemophilia A in the United States
por: Humphries, Thomas J., et al.
Publicado: (2016)

Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With Ocrelizumab
por: Geiger, Caroline K., et al.
Publicado: (2023)

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
por: Frau, Jessica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v17e8k4jpr0dtui7g11sg4i4lq